135 related articles for article (PubMed ID: 22416050)
21. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
[TBL] [Abstract][Full Text] [Related]
22. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
Juskova M; Majekova M; Demopoulos V; Stefek M
Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
[TBL] [Abstract][Full Text] [Related]
23. Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model.
La Motta C; Sartini S; Salerno S; Simorini F; Taliani S; Marini AM; Da Settimo F; Marinelli L; Limongelli V; Novellino E
J Med Chem; 2008 Jun; 51(11):3182-93. PubMed ID: 18452283
[TBL] [Abstract][Full Text] [Related]
24. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Giovannoni MP; Dal Piaz V; Vianello P; Barlocco D
J Med Chem; 1999 Jun; 42(11):1894-900. PubMed ID: 10354397
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
Van Zandt MC; Jones ML; Gunn DE; Geraci LS; Jones JH; Sawicki DR; Sredy J; Jacot JL; Dicioccio AT; Petrova T; Mitschler A; Podjarny AD
J Med Chem; 2005 May; 48(9):3141-52. PubMed ID: 15857120
[TBL] [Abstract][Full Text] [Related]
26. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A
Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.
Wang QQ; Cheng N; Zheng XW; Peng SM; Zou XQ
Bioorg Med Chem; 2013 Jul; 21(14):4301-10. PubMed ID: 23683835
[TBL] [Abstract][Full Text] [Related]
28. A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity.
Alexiou P; Demopoulos VJ
J Med Chem; 2010 Nov; 53(21):7756-66. PubMed ID: 20936791
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth muscle cell proliferation.
Chung HJ; Jung OJ; Chae MJ; Hong SY; Chung KH; Lee SK; Ryu CK
Bioorg Med Chem Lett; 2005 Jul; 15(14):3380-4. PubMed ID: 15950466
[TBL] [Abstract][Full Text] [Related]
31. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
[TBL] [Abstract][Full Text] [Related]
32. Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step.
Ramunno A; Cosconati S; Sartini S; Maglio V; Angiuoli S; La Pietra V; Di Maro S; Giustiniano M; La Motta C; Da Settimo F; Marinelli L; Novellino E
Eur J Med Chem; 2012 May; 51():216-26. PubMed ID: 22436396
[TBL] [Abstract][Full Text] [Related]
33. Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
Van Zandt MC; Doan B; Sawicki DR; Sredy J; Podjarny AD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2006-8. PubMed ID: 19250825
[TBL] [Abstract][Full Text] [Related]
34. (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
Stefek M; Tsantili-Kakoulidou A; Milackova I; Juskova M; Snirc V; Triantos N
Bioorg Med Chem; 2011 Dec; 19(23):7181-5. PubMed ID: 22037047
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Miyashiro J; Woods KW; Park CH; Liu X; Shi Y; Johnson EF; Bouska JJ; Olson AM; Luo Y; Fry EH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4050-4. PubMed ID: 19553114
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
[TBL] [Abstract][Full Text] [Related]
37. [1-(3,5-difluoro-4-hydroxyphenyl)-1H-pyrrol-3-yl]phenylmethanone as a bioisostere of a carboxylic acid aldose reductase inhibitor.
Nicolaou I; Zika C; Demopoulos VJ
J Med Chem; 2004 May; 47(10):2706-9. PubMed ID: 15115413
[TBL] [Abstract][Full Text] [Related]
38. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
Steuber H; Heine A; Klebe G
J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
[TBL] [Abstract][Full Text] [Related]
39. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
[TBL] [Abstract][Full Text] [Related]
40. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
